|
Bicalutamide Clinical Trials
7 actively recruiting trials across 5 locations
Also known as: Bicalutamide Teva, Casodex, Cassotide, Cosudex, ICI 176,334 +3 more
Pipeline
Phase 2: 3Phase 3: 3Phase 1/2: 1
Top Sponsors
- Universitaire Ziekenhuizen KU Leuven1
- SWOG Cancer Research Network1
- NRG Oncology1
- Icahn School of Medicine at Mount Sinai1
- Emory University1
Indications
- Cancer7
- Stage IVA Prostate Cancer AJCC v83
- Stage IVB Prostate Cancer AJCC v82
- Stage IV Prostate Cancer AJCC v82
- Breast Cancer2
Other2 trials
Birmingham, Alabama1 trial
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
University of Alabama at Birmingham Cancer Center
Phase 3
Gilbert, Arizona1 trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Banner MD Anderson Cancer Center
Phase 3
Duarte, California1 trial
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
City of Hope Medical Center
Phase 2
Atlanta, Georgia1 trial
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Emory Proton Therapy Center
Phase 3
New York, New York1 trial
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Mount Sinai Beth Israel
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.